aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
Provided By GlobeNewswire
Last update: Mar 12, 2025
Peer-reviewed publication validates efzofitimod’s unique anti-inflammatory mechanism of action on macrophages through neuropilin-2 (NRP2) receptor.
Scientific insights further strengthen the rationale for clinical program for efzofitimod in interstitial lung disease (ILD).
Read more at globenewswire.com
